SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-018019
Filing Date
2021-04-07
Accepted
2021-04-07 16:18:11
Documents
14
Period of Report
2021-04-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kdny-8k_20210407.htm   iXBRL 8-K 37060
2 EX-99.1 kdny-ex991_59.htm EX-99.1 363712
3 GRAPHIC gemymxgndzzb000001.jpg GRAPHIC 67035
  Complete submission text file 0001564590-21-018019.txt   645409

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kdny-20210407.xsd EX-101.SCH 5792
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20210407_lab.xml EX-101.LAB 20224
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20210407_pre.xml EX-101.PRE 12102
7 EXTRACTED XBRL INSTANCE DOCUMENT kdny-8k_20210407_htm.xml XML 3694
Mailing Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 21812320
SIC: 2834 Pharmaceutical Preparations